Press & news

Press releases

Matt Franklin, MBA, appointed as Biofidelity Non-Executive Director

Matt Franklin, MBA, appointed as Biofidelity Non-Executive Director

Nov 17. 2022
Biofidelity has expanded its Board of Directors to include Matt Franklin, MBA, who will join as a Non-Executive Director.
Biofidelity announces presentation of new data on novel genomic technology at AMP 2022

Biofidelity announces presentation of new data on novel genomic technology at AMP 2022

Oct 28. 2022
ASPYRE simplifies & accelerates the detection of biomarkers in both DNA & RNA to facilitate selection of the most effective targeted cancer treatments
New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA

New data demonstrates novel genomic technology provides ultra-sensitive detection of gene fusions from RNA

Oct 18. 2022
Current sequencing methods miss gene fusions for many non-small cell lung cancer patients denying them access to targeted therapies.
View all press releases

News

Biofidelity announces first peer reviewed publication of breakthrough ASPYRE technology | Biofidelity

Biofidelity announces first peer reviewed publication of breakthrough ASPYRE technology | Biofidelity

Mar 23. 2021
Publication validates the ability of ASPYRE to detect single copies of somatic variants in tissue and plasma Cambridge, UK, 23 March 2021 – Biofidelity …
Biofidelity appoints Robert Osborne as Chief Operating Officer | Biofidelity

Biofidelity appoints Robert Osborne as Chief Operating Officer | Biofidelity

Dec 10. 2020
Biofidelity Ltd, the cancer diagnostics company, today announces the further expansion of its leadership team with the appointment of Dr. Robert Osborne as …
Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology | Biofidelity

Biofidelity raises $12m in Series A financing to accelerate launch of disruptive cancer diagnostic technology | Biofidelity

Aug 20. 2020
Supported by BlueYard Capital, Longwall Ventures and Agilent Technologies Funds to be used to bring technology to market, enabling a dramatic simplification …
View all news articles